The fundamentals of Asia’s healthcare sector are attractive, driven by the region’s ageing societies, the emergence of new treatments in gene therapy and in innovative drug development, changing demographics in China and a hotbed of technological developments. Opportunities in IPOs, private equity, venture capital and in M&As are emerging for investors of all type. And major institutions like insurance firms, pension funds, sovereign wealth funds and those representing UHNI have started to pay attention. 

FinanceAsia is launching the Financing Healthcare Week at a crucial time for the industry—as the world gets used to the pandemic and starts its recovery. The event will bring together the entire capital markets ecosystem, from long-term investors, both in debt and equity and to major issuers and from pre-IPO startups chief scientific officers. The event will identify trends in Asia’s healthcare sector so that investors can capitalise on the substantial opportunities emerging.

Want to receive the latest industry stories and updates? Subscribe to our newsletter now!